1. MP49-15 OVERACTIVE BLADDER MEDICATION; HOW LONG SHOULD IT BE CONTINUED? - MIRABEGRON INTERFERES WITH CENTRAL SENSITIZATION IN A MOUSE MODEL OF OVERACTIVE BLADDER. (May 2022) Authors: Kwon, Joonbeom; Lee, Eun-Ju; Park, Hye-Ri; Cho, Hyun-Jung; Jang, Ji-Ae; Park, Donghwi; Yoshimura, Naoki Journal: Journal of urology Issue: Volume 207(2022)Supplement 5 Page Start: e859 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PD08-07 ANTIFIBROSIS TREATMENT IMPROVES BLADDER DYSFUNCTION AND PAIN PERCEPTION IN A MOUSE MODEL OF BLADDER PAIN WITH CENTRAL SENSITIZATION MIMICKING INTERSTITIAL CYSTITIS. (May 2022) Authors: Kwon, Joonbeom; Park, Hye-Ri; Lee, Eun-Ju; Jang, Ji-Ae; Cho, Hyun-Jung; Yoshimura, Naoki Journal: Journal of urology Issue: Volume 207(2022)Supplement 5 Page Start: e107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗